Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nucleoside Derivatives - 6-Modified purine nucleosides; Drugs and Inhibitors; Prodrug of anticancer agent 6-methylpurine; used for gene therapy
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | Inquiry | |
10 mg | 5 days | Inquiry | |
25 mg | 5 days | Inquiry | |
50 mg | 5 days | Inquiry | |
100 mg | 5 days | Inquiry | |
500 mg | 5 days | Inquiry |
Description | Nucleoside Derivatives - 6-Modified purine nucleosides; Drugs and Inhibitors; Prodrug of anticancer agent 6-methylpurine; used for gene therapy |
Molecular Weight | 250.25 |
Formula | C11H14N4O3 |
CAS No. | 16006-64-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine 16006-64-7 inhibitor inhibit